Effectiveness of Arestin in Patients Who Smoke

by Jessica Sanders 2 months ago in feature

Recently, the use of local treatment has increased in treating periodontal patients. This approach allows to increase drug concentration needed for reducing the cases of periodontal infections. Moreover, some studies indicate the efficacy of such treatment in reducing the inter-pockets among the smoker patients. Smoking does not only increase the frequency, but also contributes to the severity of the periodontal disease. Thus, smoking increases the rates of periodontitis among individuals.

Effectiveness of Arestin in Patients Who Smoke

Arestin can be defined as an antibiotic drug used by dental specialists in treating periodontal diseases in humans. The medicine is usually sold in powder form, making it easy to administer it to the patients. In addition, clinical studies have confirmed that Arestin is actually more effective than any other form of treatment, including the use of scaling and root planing (SRP). However, over the years, smoking has been seen as a detriment to the treatment of periodontal patients who smoke. Nevertheless, since the introduction of Arestin, it has proven to be very effective in tackling the disease among the patients who smoke. This paper will make an attempt to provide a comprehensive discussion of the effectiveness of Arestin in smoker patients. It will also evaluate past studies of other treatment options, such as SRP and their effectiveness when compared to the use of Arestin. Therefore, the paper will analyze the nature of Arestin and its effectiveness among smoker patients.

Background

Arestin is a new locally administered antibiotic proven more effective than other methods of treatment. However, clinical studies and research suggest that Arestin should be prescribed with caution and after a thorough review of a patient’s medical history. For instance, people who smoke may be at risk of contracting oral candidiasis after the use of Arestin. Moreover, patients who smoke are at a high risk of developing periodontal diseases. Smoking causes more than 50 percent of adult periodontal cases across the world. The disease destroys the gum tissues and bones supporting human teeth. It further allows for the formation of pockets, which in turn increases the accumulation of bacteria. Most smokers exhibit an increase in the rate of gingival reduction, loss of alveolar bone, loss of tooth, increased furcations, and increased depth of the pockets. Some clinical studies have linked periodontal diseases to other human health problems such as stroke and diabetes. Apart from all, the use of Arestin causes some side effects including infection, headache, pain, and flu syndrome. The patients should be well aware of the side effects before starting the treatment. However, Arestin does not change the taste nor does it cause stomach upset or stain teeth. Thus, there is the need to control the level of adverse effects caused by smoking by the use of Arestin. As a result, the use of Arestin is more effective among patients who smoke, compared to other periodontal disease treatment options.

Before its introduction into the common use, Arestin has been well-researched and documented as one of the most effective treatments among smoker patients with periodontal disease diagnosis. The research on Arestin provides a better understanding of the systemic effects of Arestin associated with the disease processes. Arestin will improve the oral care, and dental practitioners will be able to educate and provide effective treatment to the smoker patients. Moreover, the effectiveness of Arestin has been documented as a major contribution to delivering superior results in periodontal therapy. The selection of Arestin guarantees more than 100 per cent efficiency in enhancing the treatment outcomes among the smoker patients. However, it should be noted that all clinical procedures, including the administration of the drug, must be kept under strict control to avoid any medical errors.

The dental practitioners are expected to screen the patients for any past medical history that could hinder the Arestin treatment approach. It includes x-ray examining and regular periodontal reviews on the patient’s health. Other significant periodontal examinations include mobility tests, furcation readings and fremitus. The readings are necessary to meet the requirement of proper diagnosis. Since it is recognized that smoking increases the prevalence of dental bone loss, smoker patients’ records are used to evaluate the effectiveness of Arestin. The introduction of nicotine into the gums leads to the reduction of oxygen and white blood cells in the gums. It reduces the immunity of the cells around the teeth to fight off bacterial infections. It increases the prevalence of periodontal diseases among smoking individuals.

A group of scientists have performed a study on the effectiveness of Arestin on periodontitis therapy in patients with smoking status. The study was critical in understanding the antimicrobial and clinical effects of Arestin on such patients. The study involved a multi-center clinical trial of 127 patients diagnosed with periodontitis at the hospitals. The patients were divided into current and never smoking individuals, in terms of the controlled experiment. The study sought to determine the effects of smoking on the prevalence of periodontal disease among the smoker patients. The findings of the study determined that the use of Arestin leads to a significant reduction of the current smoker’s situation. They also combined Arestin with SRP, obtaining indications that Arestin alone was more effective. After the experiment, there was a follow up of 10 days to control whether the patients treated with Arestin were still recovering well.

Another study included 900 smoker patients are in the United States. The clinical trials were very important. They allowed the collection of increased data for determining the safety of Arestin. The study was also crucial in reporting various side effects such as placebo. In addition, the effectiveness of Arestin is based on the fact that it is an antibiotic. The nature of periodontal disease is caused by bacterial infection that requires antibiotics for effective treatment. Arestin, unlike the SRP procedure, has the best collection of antibiotic properties to treat periodontal disease. Arestin facilitates the complete elimination of bacteria in the teeth gums and bones. The level of pocket depth was a relevant measurement to determine the effectiveness of Arestin in treating the disease. Thus, the reduction of the pocket depths indicated that the drug treatment was effective.

Moreover, Arestin contains the antibiotic minocycline hydrochloride that makes it bioresorbable. This feature has made Arestin even more effective in treating periodontal pockets. The introduction of Arestin was done after several researches on various bacteria samples. During the studies, there was an increase in the level of resistant bacteria to the drugs, but their number was very small and could not establish any clinical significance. Repeated studies of the drug indicated that there were no changes in the level of the drug-resistant bacteria. It ensures that Arestin is ready for treating bacteria that cause periodontal pockets among smoker patients. It was also discovered that Arestin can be used in the periodontal maintenance program to promote oral hygiene and scaling of teeth. Nevertheless, the efficiency of the drug has been surrounded by major contraindication. The contraindication stated that Arestin should not be given to patients with sensitivity to tetracyclines. This questions the overall effectiveness of the drug in treating patients who smoke.

The complete diagnosis and review of the patient’s history helps in promoting the effectiveness of Arestin in treating periodontal disease among the smoker patients. During the diagnosis, the dental practitioners usually face the problem of bleeding from the probing depths. However, after the administration of Arestin the blood stops allowing for the successful recovery of the patient. The smoker patient’s cases are usually severe and thus, Arestin offers comprehensive and effective treatment of the periodontal pockets. It leads to the reduction in degradation of gums and bones caused by destructive enzymes. Moreover, Arestin ensures that the problem does not recur. This can be achieved since Arestin increases clinical attachment levels that are effective in eliminating cases of periodontal disease. Therefore, it is highly recommended for the smoker patients to use Arestin for treating their periodontal disease problems.

A recent study argues that the combined use of Arestin and SRP was more effective in eliminating the bacteria causing periodontal diseases. However, the use of Arestin alone among patients who smoke proved to be more than 100 percent effective in the treatment of periodontal disease. There is adequate literature to support that Arestin is more effective in eliminating the problem. It has also been determined that the use of this drug is more effective in reducing the depth of pockets in smokers suffering from periodontal diseases. Statistics shows that Arestin, within six months, reduces the pocket depth by 33 percent. It explains its high level of therapeutic effect among the patients who smoke. The reduction of the pocket depth made the drug more maintainable than other treatment options in the hospitals. Most importantly, it is easy to administer Arestin to the patients since it does not have any form of dressing or adhesive. It only requires the manipulations with the cartridge. It also does not require any form of local anesthesia. The use of Arestin among smokers increases the level of therapeutic drug concentration within 21 days. It leads to increased time for managing the infections after the treatment. This shows a higher effectiveness of Arestin among patients who smoke compared to SRP.

It is clear that the use of Arestin is effective in treating smoker patients from periodontal disease. For instance, Arestin provides a favorable outcome in treating deep periodontal pockets among smoker patients. Dental researches have documented that Arestin is more effective than any other form of treatment, including the use of scaling and root planing (SRP). However, the use of Arestin has various side effects including pain, headache, and infections among others. Nevertheless, in comparison with other methods of treatment periodontal diseases among smoker patients (such as SRP treatment), Arestin is the most effective option. In order to determine the effectiveness of such treatment, the dental physicians are required to measure the level of reduction of pocket depth in the patient’s teeth. The procedure of administering Arestin provides for the conduction of advanced diagnosis and review of the patient’s medical history the problem of periodontitis may be linked to various health conditions including stroke and diabetes. Such review and medical analysis enhance the effectiveness of using Arestin to treat smoker patients diagnosed with periodontal disease since it can be easily administered to the smoker patients.

About the author:

Jessica Sanders is a bachelor in English philology and sociology at California University. Jessica is currently working as one of the best writers at the essayswriters.com. She also studies feminine psychology.

feature
Read next: Best Running Shoes for Women
Jessica Sanders

Hi! My name is Jessica Sanders! I am a bachelor in English philology and literature at California University. I am currently working as one of the best writers at the EssaysWriters.com Also, I study feminine psychology.

See all posts by Jessica Sanders